Migone, C.; Grassiri, B.; Vizzoni, L.; Fabiano, A.; Ferro, B.; Zambito, Y.; Piras, A.M.
Aerosol of Enoximone/Hydroxypropyl-β-Cyclodextrin Inclusion Complex, Biopharmaceutical Evidence for ARDS Applicability. Pharmaceutics 2024, 16, 1221.
https://doi.org/10.3390/pharmaceutics16091221
AMA Style
Migone C, Grassiri B, Vizzoni L, Fabiano A, Ferro B, Zambito Y, Piras AM.
Aerosol of Enoximone/Hydroxypropyl-β-Cyclodextrin Inclusion Complex, Biopharmaceutical Evidence for ARDS Applicability. Pharmaceutics. 2024; 16(9):1221.
https://doi.org/10.3390/pharmaceutics16091221
Chicago/Turabian Style
Migone, Chiara, Brunella Grassiri, Lucia Vizzoni, Angela Fabiano, Baldassare Ferro, Ylenia Zambito, and Anna Maria Piras.
2024. "Aerosol of Enoximone/Hydroxypropyl-β-Cyclodextrin Inclusion Complex, Biopharmaceutical Evidence for ARDS Applicability" Pharmaceutics 16, no. 9: 1221.
https://doi.org/10.3390/pharmaceutics16091221
APA Style
Migone, C., Grassiri, B., Vizzoni, L., Fabiano, A., Ferro, B., Zambito, Y., & Piras, A. M.
(2024). Aerosol of Enoximone/Hydroxypropyl-β-Cyclodextrin Inclusion Complex, Biopharmaceutical Evidence for ARDS Applicability. Pharmaceutics, 16(9), 1221.
https://doi.org/10.3390/pharmaceutics16091221